As activated B cell (ABC)-DLBCL cells are defined by a transcriptional signature similar to B cells poised for terminal differentiation, the distinct roles for RelA and cRel seen in healthy B cells are consistent with the emerging understanding of subunit-specific roles in lymphoma, with cRel particularly implicated in GC-DLBCL [40]. Here, REL is linked to diffuse large B-cell lymphoma.